https://www.wsj.com/health/pharma/zepbound-wegovy-weight-loss-switch-cvs-caremark-fe3b7b7c
0
0
7/27/25 at 2:57pm
Organization
The Wall Street Journal
Author
Peter Loftus
34 words
0
Comments
Some shift to save money in response to CVS Caremark restrictions; others appeal for Zepbound coverage, citing better weight-loss results
You are the first to view
Create an account
or login to join the discussion